Description

3,8-Dibromodiimidazo[1,2-A:2',1'-C]Pyrazine is a high-purity, heterocyclic organic compound featuring a fused diimidazopyrazine core with bromine substituents. This specialized brominated intermediate is valued for its unique reactivity and structural properties, enabling advanced synthesis in demanding research and development applications. It is primarily sought by pharmaceutical, agrochemical, and advanced materials chemists for use as a key building block in the creation of novel active ingredients and functional molecules.

Application

• Pharmaceutical Intermediate: Serves as a critical precursor in the synthesis of novel drug candidates, particularly those targeting specific biological pathways where its fused heterocyclic structure is advantageous.
• Agrochemical Research: Used in the development of new pesticides and herbicides, where the bromine atoms can be further functionalized to create compounds with specific modes of action.
• Material Science: Acts as a building block for organic electronic materials, such as ligands for metal-organic frameworks (MOFs) or components in organic semiconductors, due to its electron-deficient aromatic system.
• Chemical Synthesis: Employed in cross-coupling reactions (e.g., Suzuki, Buchwald-Hartwig) where the bromine atoms serve as excellent leaving groups for introducing diverse functional groups.
• Ligand & Catalyst Development: Utilized in the preparation of novel nitrogen-donor ligands for transition metal catalysis.
• Life Sciences Research: Functions as a molecular probe or a tagged compound in biochemical and medicinal chemistry studies.

Basic Information

Product Name	3,8-Dibromodiimidazo[1,2-A:2',1'-C]Pyrazine
CAS No.	58860-37-0
Molecular Formula	C8H4Br2N4
Molecular Weight	307.95 g/mol
Synonyms	3,8-Dibromodiimidazo[1,2-a:2',1'-c]pyrazine; Diimidazo[1,2-a:2',1'-c]pyrazine, 3,8-dibromo-; 3,8-Dibromo-diimidazo[1,2-a:2',1'-c]pyrazine; 3,8-Dibromoimidazo[1,2-a]imidazo[1,2-c]pyrazine; 58860-37-0; AI3-52010; SCHEMBL2182906; CTK8G7275
EINECS	Contact for details

Quality Control

Our 3,8-Dibromodiimidazo[1,2-A:2',1'-C]Pyrazine is manufactured under strict quality management systems. Each batch undergoes comprehensive analytical testing, including HPLC for purity, NMR and IR for structural confirmation, and residual solvent analysis, to ensure it meets the high standards required for research and scale-up applications. A detailed Certificate of Analysis (COA) is provided with every shipment to guarantee traceability, consistency, and compliance with your specifications.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, well-ventilated place at controlled room temperature (typically 15-25°C). Keep away from incompatible materials. Due to its light-sensitive nature, handling and packaging are performed under low-light conditions to preserve stability.

Specification

Item	Specification
Appearance	Off-white to light yellow crystalline powder
Identification (IR)	Conforms to structure
Identification (NMR)	Conforms to structure
Purity (HPLC)	≥ 97.0% (Area %)
Melting Point	Contact for details
Loss on Drying	≤ 0.5%
Residual Solvents (GC)	Meets ICH guidelines

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.